If the absence of ACE2 expression in blood cells is confirmed to be premorbid and constitutive, then efforts at outreach, screening, and prevention of COVID-19 or PCC can target this quarter of the population with high efficiency. The gene discussed is ACE2; the disease is COVID-19.